D

Day One Biopharmaceuticals Inc
NASDAQ:DAWN

Watchlist Manager
Day One Biopharmaceuticals Inc
NASDAQ:DAWN
Watchlist
Price: 13.72 USD 2.85% Market Closed
Market Cap: 1.4B USD
Have any thoughts about
Day One Biopharmaceuticals Inc?
Write Note

Wall Street
Price Targets

DAWN Price Targets Summary
Day One Biopharmaceuticals Inc

Wall Street analysts forecast DAWN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DAWN is 37.74 USD with a low forecast of 28.28 USD and a high forecast of 50.4 USD.

Lowest
Price Target
28.28 USD
106% Upside
Average
Price Target
37.74 USD
175% Upside
Highest
Price Target
50.4 USD
267% Upside

DAWN Last Price Targets
Day One Biopharmaceuticals Inc

The latest public price target was made on Aug 1, 2024 by Alec Stranahan from Bank of America Securities , who expects DAWN stock to rise by 75% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Alec Stranahan
Bank of America Securities
24 USD
Upside 75%
3 months ago
Aug 1, 2024
Day One Biopharmaceuticals upgraded to Buy from Underperform at BofA
TheFly
Andrew Maldonado
H.C. Wainwright
40 USD
Upside 192%
6 months ago
May 7, 2024
Day One Biopharmaceuticals (DAWN) PT Lowered to $40 at H.C. Wainwright
StreetInsider
Alec Stranahan
Bank of America Securities
Price Target 24 USD
Upside/Downside 75%
View Source
Andrew Maldonado
H.C. Wainwright
Price Target 40 USD
Upside/Downside 192%
View Source
Day One Biopharmaceuticals Inc Competitors:
Price Targets
377740
BioNote Inc
26% Upside
214450
PharmaResearch Co Ltd
40% Upside
688373
Shanghai MicuRx Pharmaceutical Co Ltd
39% Upside
ORY
Oryzon Genomics SA
299% Upside
688520
Sinocelltech Group Ltd
76% Upside
ALRN
Aileron Therapeutics Inc
437% Upside
096530
Seegene Inc
68% Upside
SWTX
SpringWorks Therapeutics Inc
77% Upside

Revenue
Forecast

Revenue Estimate
Day One Biopharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Day One Biopharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Day One Biopharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DAWN's stock price target?
Price Target
37.74 USD

According to Wall Street analysts, the average 1-year price target for DAWN is 37.74 USD with a low forecast of 28.28 USD and a high forecast of 50.4 USD.

Back to Top